(Q34172105)

31 July 2017

MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis (English)

1 reference

31 July 2017

1 reference

Catherine Thériault

1

1 reference

31 July 2017

Maxime Pinard

2

1 reference

31 July 2017

Marina Comamala

3

1 reference

31 July 2017

Martine Migneault

4

1 reference

31 July 2017

Julie Beaudin

5

1 reference

31 July 2017

Isabelle Matte

6

1 reference

31 July 2017

Marianne Boivin

7

1 reference

31 July 2017

Alain Piché

8

1 reference

31 July 2017

Claudine Rancourt

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

21 March 2011

1 reference

31 July 2017

1 reference

31 July 2017

121

1 reference

31 July 2017

3

1 reference

31 July 2017

434-443

1 reference

Epithelial ovarian cancer: prevention, diagnosis, and treatment

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Focus on epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Evaluation of serum CA 125 levels in the monitoring of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Ovarian cancer antigen CA 125 enhances the invasiveness of the endometriotic cell line EEC 145.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Purification and characterization of the CA 125 tumor-associated antigen from human ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Molecular characteristics of the CA 125 antigen produced by human endometrial epithelial cells: comparison between eutopic and heterotopic epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Characterization of CA 125 synthesized by the human epithelial amnion WISH cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

The CA 125 gene: an extracellular superstructure dominated by repeat sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

7 January 2021

Epithelial mucin genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Epithelial-mesenchymal transition in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Epithelial-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Epithelial-mesenchymal transitions in tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Molecular requirements for epithelial-mesenchymal transition during tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

E-cadherin germline mutations in familial gastric cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

Epidermal growth factor enhances secretion of the ovarian tumor-associated cancer antigen CA125 from the human amnion WISH cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.020

10.1016/J.YGYNO.2011.02.020

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference